SEC Form 4 research
| Issuer | Alamar Biosciences, Inc. |
|---|---|
| Tickers | ALMR |
| Reporting owners | 21 |
| Officers and directors | 1 |
| Last public filing | 2026-09-16 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-16 | 2026-09-14 | Brottem John L. | A | 29,000 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Brottem John L. | A | 85,000 | $0 | Not reported |
| 2026-09-03 | 2026-09-01 | RAGUSA ROBERT P | A | 5,686 | $0 | Not reported |
| 2026-09-03 | 2026-09-01 | RAGUSA ROBERT P | A | 25,599 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.